Toggle Main Menu Toggle Search

Open Access padlockePrints

A phase 1 experimental medicine study of anti-CD3 monoclonal antibody in rheumatoid arthritis

Lookup NU author(s): Dr Rachel Harry, Dr Bridget Griffiths, Dr Geoff Hale, Professor John IsaacsORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Lawson CA, Harry R, Griffiths B, Hale G, Waldmann H, Isaacs JD

Publication type: Article

Publication status: Published

Journal: Immunotherapy Advances

Year: 2025

Volume: 5

Issue: 1

Online publication date: 03/12/2025

Acceptance date: 06/11/2025

Date deposited: 06/05/2026

ISSN (electronic): 2732-4303

Publisher: Oxford University Press

URL: https://doi.org/10.1093/immadv/ltaf034

DOI: 10.1093/immadv/ltaf034

Data Access Statement: The data underlying this article are available within the article.

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder referenceFunder name
Arthritis Research UK Clinical Research Fellowship
Arthritis Research UK Newcastle Biomedicine Experimental Arthritis Treatment Centre
EP Abrahams Trust (Oxford, UK)
GSK
JGWP Trust
Millennium Pharmaceuticals Inc. (Cambridge, Massachusetts, USA)
National Institute for Health and Care Research Newcastle Biomedical Research Centre
Tolerx Inc. (Cambridge, Massachusetts, USA)

Share